Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Arrowhead Research Corp (NASDAQ:ARWR)

5.67
Delayed Data
As of Aug 27
 +0.14 / +2.53%
Today’s Change
4.35
Today|||52-Week Range
17.42
-23.17%
Year-to-Date
No recent news for Arrowhead Research Corp.

Today’s Trading

Previous close5.53
Today’s open5.63
Day’s range5.48 - 5.74
Volume947,393
Average volume (3 months)1,062,146
Market cap$329.0M
Dividend yield--
Data as of 08/27/2015

Growth & Valuation

Earnings growth (last year)+3.85%
Earnings growth (this year)-28.80%
Earnings growth (next 5 years)--
Revenue growth (last year)-39.71%
P/E ratioNM
Price/Sales3,961.15
Price/Book1.81

Competitors

 Today’s
change
Today’s
% change
BSTCBiospecifics Technol...+1.49+3.07%
ONTYOncothyreon Inc+0.17+5.06%
AMRNAmarin Corporation P...+0.19+10.00%
NVIVInVivo Therapeutics ...-0.33-3.42%
Data as of 08/27/2015

Financials

Next reporting dateDecember 22, 2015
EPS forecast (this quarter)-$0.39
Annual revenue (last year)$175.0K
Annual profit (last year)-$58.6M
Net profit margin-33,502.97%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Christopher Richard Anzalone
Chief Operating Officer
Bruce D. Given
Corporate headquarters
Pasadena, California

Forecasts

Partner Offers